## Abstract ## BACKGROUND: Both concomitant chemotherapy and altered fractionation radiotherapy (RT) have been shown to improve outcomes for patients with locoregionally advanced head and neck squamous cell carcinomas. However, both strategies also increase acute toxicity, and it is questionable w
Concurrent cisplatin and radiotherapy in advanced head and neck cancer
β Scribed by Rehan Asif; Kamlesh Chandra; Vanita Chopra; M. L. B. Bhatt
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 250 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0019-5421
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In 22 patients with advanced squamous cell carcinoma of the head and neck we evaluated the efficacy and toxicity of 200 mg/m2 cisplatin administered in 3% NaCl with vigorous hydration. Six patients had previously untreated stage IV disease and 16 patients had recurrent disease, including eight with
## Abstract In a prospective evaluation, two preoperative courses of methotrexate, bleomycin, and cisplatin combined with 2,000 rad/10 fractions (βchemoβradiotherapyβ) yielded 78% response rates in previously untreated advanced head and neck cancer. Similarly staged patients receiving preoperative
## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de